Patents Assigned to Ersai R&D Management Co., Ltd.
  • Substituted liposaccharides useful in the treatment and prevention of endotoxemia
    Patent number: 7994154
    Abstract: Novel substituted liposaccharides useful as in the prophylactic and affirmative treatment of endotoxemia including sepsis, septicemia and various forms of septic shock and methods of using these agents are provided. Also provided are methods of preparing these agents and intermediates useful therein.
    Type: Grant
    Filed: May 17, 2010
    Date of Patent: August 9, 2011
    Assignee: Ersai R&D Management Co., Ltd.
    Inventors: William J. Christ, Daniel P. Rossignol, Seiichi Kobayashi, Tsutomu Kawata